Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT in children and young adults with relapsed or refractory AML
NCT00606723Phase 3Completed
- Sponsor
- Hannover Medical School
- Start
- Apr 2010
- Primary completion
- Feb 2021
- Modality
- Stem Cell Therapies
- Countries
- 3
01
Overview
Phase 3, open-label trial of hematopoietic stem cells in acute myeloid leukemia (AML), sponsored by Hannover Medical School. Started Apr 2010; status: completed.
02
Drugs
hematopoietic stem cells
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00606723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00606723.